Labcorp Holdings EPS - Earnings per Share 2011-2025 | LH
- Labcorp Holdings EPS for the quarter ending September 30, 2025 was $3.12, a 56% increase year-over-year.
- Labcorp Holdings EPS for the twelve months ending September 30, 2025 was $10.20, a 93.55% increase year-over-year.
- Labcorp Holdings 2024 annual EPS was $8.84, a 85.32% increase from 2023.
- Labcorp Holdings 2023 annual EPS was $4.77, a 65.86% decline from 2022.
- Labcorp Holdings 2022 annual EPS was $13.97, a 42.72% decline from 2021.
| Labcorp Holdings Annual EPS | |
|---|---|
| 2024 | $8.84 |
| 2023 | $4.77 |
| 2022 | $13.97 |
| 2021 | $24.39 |
| 2020 | $15.88 |
| 2019 | $8.35 |
| 2018 | $8.61 |
| 2017 | $11.81 |
| 2016 | $6.82 |
| 2015 | $4.35 |
| 2014 | $5.91 |
| 2013 | $6.25 |
| 2012 | $5.99 |
| 2011 | $5.11 |
| 2010 | $5.29 |
| Labcorp Holdings Quarterly EPS | |
|---|---|
| 2025-09-30 | $3.12 |
| 2025-06-30 | $2.84 |
| 2025-03-31 | $2.52 |
| 2024-12-31 | $1.72 |
| 2024-09-30 | $2.00 |
| 2024-06-30 | $2.43 |
| 2024-03-31 | $2.69 |
| 2023-12-31 | $-1.85 |
| 2023-09-30 | $2.11 |
| 2023-06-30 | $2.12 |
| 2023-03-31 | $2.39 |
| 2022-12-31 | $0.97 |
| 2022-09-30 | $3.90 |
| 2022-06-30 | $3.87 |
| 2022-03-31 | $5.23 |
| 2021-12-31 | $5.76 |
| 2021-09-30 | $6.05 |
| 2021-06-30 | $4.76 |
| 2021-03-31 | $7.82 |
| 2020-12-31 | $9.61 |
| 2020-09-30 | $7.17 |
| 2020-06-30 | $2.37 |
| 2020-03-31 | $-3.27 |
| 2019-12-31 | $2.31 |
| 2019-09-30 | $2.25 |
| 2019-06-30 | $1.93 |
| 2019-03-31 | $1.86 |
| 2018-12-31 | $1.57 |
| 2018-09-30 | $3.10 |
| 2018-06-30 | $2.27 |
| 2018-03-31 | $1.67 |
| 2017-12-31 | $6.63 |
| 2017-09-30 | $1.65 |
| 2017-06-30 | $1.78 |
| 2017-03-31 | $1.75 |
| 2016-12-31 | $1.57 |
| 2016-09-30 | $1.71 |
| 2016-06-30 | $1.96 |
| 2016-03-31 | $1.58 |
| 2015-12-31 | $1.15 |
| 2015-09-30 | $1.50 |
| 2015-06-30 | $1.66 |
| 2015-03-31 | $0.04 |
| 2014-12-31 | $1.37 |
| 2014-09-30 | $1.59 |
| 2014-06-30 | $1.64 |
| 2014-03-31 | $1.31 |
| 2013-12-31 | $1.44 |
| 2013-09-30 | $1.63 |
| 2013-06-30 | $1.62 |
| 2013-03-31 | $1.56 |
| 2012-12-31 | $1.27 |
| 2012-09-30 | $1.53 |
| 2012-06-30 | $1.56 |
| 2012-03-31 | $1.63 |
| 2011-12-31 | $1.37 |
| 2011-09-30 | $1.31 |
| 2011-06-30 | $1.20 |
| 2011-03-31 | $1.23 |
| 2010-12-31 | $1.24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.446B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.807B | 27.32 |
| HCA Healthcare (HCA) | United States | $107.561B | 17.81 |
| CVS Health (CVS) | United States | $99.854B | 11.48 |
| Elevance Health (ELV) | United States | $69.881B | 10.25 |
| Cencora (COR) | United States | $69.843B | 22.53 |
| Natera (NTRA) | United States | $27.241B | 0.00 |
| DiDi Global (DIDIY) | China | $24.615B | 20.11 |
| Medpace Holdings (MEDP) | United States | $16.681B | 41.41 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.398B | 0.00 |
| ICON (ICLR) | Ireland | $12.921B | 12.82 |
| CochLear (CHEOY) | Australia | $12.049B | 0.00 |
| Viatris (VTRS) | United States | $11.672B | 4.34 |
| Solventum (SOLV) | United States | $11.492B | 11.16 |
| Revvity (RVTY) | United States | $10.149B | 18.69 |
| Charles River Laboratories (CRL) | United States | $8.410B | 16.20 |
| HealthEquity (HQY) | United States | $7.990B | 31.98 |
| Avantor (AVTR) | United States | $7.718B | 11.79 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.944B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.618B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.879B | 35.05 |
| Bausch + Lomb (BLCO) | Canada | $5.501B | 36.12 |
| Sotera Health (SHC) | United States | $4.548B | 21.93 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.984B | 70.41 |
| Alignment Healthcare (ALHC) | United States | $3.300B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.771B | 34.85 |
| Concentras Parent (CON) | United States | $2.398B | 14.97 |
| Premier (PINC) | United States | $2.323B | 22.51 |
| Ardent Health (ARDT) | United States | $2.069B | 7.99 |
| PACS (PACS) | United States | $1.902B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.880B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.874B | 11.19 |
| Organon (OGN) | United States | $1.744B | 1.90 |
| Progyny (PGNY) | United States | $1.549B | 30.52 |
| Teladoc Health (TDOC) | United States | $1.352B | 0.00 |
| Omada Health (OMDA) | $1.259B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.098B | 17.56 |
| Embecta (EMBC) | United States | $0.787B | 4.61 |
| CareDx (CDNA) | United States | $0.772B | 12.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 9.75 |
| Nutex Health (NUTX) | United States | $0.676B | 10.24 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Pomdoctor - (POM) | China | $0.616B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.587B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| So-Young (SY) | China | $0.434B | 0.00 |
| CryoPort (CYRX) | United States | $0.417B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.409B | 6.14 |
| Enhabit (EHAB) | United States | $0.390B | 17.52 |
| Strata Critical Medical (SRTA) | United States | $0.380B | 0.00 |
| Oncology Institute (TOI) | United States | $0.356B | 0.00 |
| Charming Medical (MCTA) | $0.350B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.320B | 7.00 |
| KindlyMD (NAKA) | United States | $0.320B | 0.00 |
| Agilon Health (AGL) | United States | $0.289B | 0.00 |
| LifeMD (LFMD) | United States | $0.249B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.228B | 0.00 |
| Beauty Health (SKIN) | United States | $0.164B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.146B | 24.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.028B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.78 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |